clinical assessment and management of nonalcoholic fatty liver disease 10.04.1403
Agenda
- DEFINITIONS
- UPDATE ON EPIDEMIOLOGY AND NATURAL HISTORY
- MOLECULAR AND CELLULAR PATHOGENESIS
- COMORBID CONDITIONS ASSOCIATED WITH NAFLD
- INITIAL EVALUATION OF A PATIENT WITH NAFLD
- ASSOCIATED ENDOCRINE DISORDERS
- WHICH PATIENTS SHOULD BE SCREENED
- TREATMENT
